| Product NDC: | 50242-140 |
| Proprietary Name: | ERIVEDGE |
| Non Proprietary Name: | vismodegib |
| Active Ingredient(s): | 150 mg/1 & nbsp; vismodegib |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 50242-140 |
| Labeler Name: | Genentech, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA203388 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20120130 |
| Package NDC: | 50242-140-01 |
| Package Description: | 1 BOTTLE, PLASTIC in 1 CARTON (50242-140-01) > 28 CAPSULE in 1 BOTTLE, PLASTIC |
| NDC Code | 50242-140-01 |
| Proprietary Name | ERIVEDGE |
| Package Description | 1 BOTTLE, PLASTIC in 1 CARTON (50242-140-01) > 28 CAPSULE in 1 BOTTLE, PLASTIC |
| Product NDC | 50242-140 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | vismodegib |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20120130 |
| Marketing Category Name | NDA |
| Labeler Name | Genentech, Inc. |
| Substance Name | VISMODEGIB |
| Strength Number | 150 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Hedgehog Pathway Inhibitor [EPC],Smoothened Receptor Antagonists [MoA] |